Videos

Third Quarter 2023 Financial Results and Business Update

February 19, 2024

Share
Tweet
Share on Facebook
Share

Third Quarter 2023 Financial Results & Business Update

Volition’s Group Chief Executive Officer, Cameron Reynolds provides an overview of the company’s third quarter 2023 financial results and business update

Press Releases
VolitionRx Appoints LifeSci Advisors as Investor Relations Consultants
Press Releases
Study shows Nu.Q® Lung Cancer Test differentiated malignant and benign nodules found by Low Dose CT screening.

Share
Tweet
Share on Facebook
Share

Subscribe for Volition product updates.

Or, click here for Investor Updates and press releases.

"*" indicates required fields

Receive product updates for:

Animal Health

Human Health

Name*

First Name Last Name

Company Name*

Your Email Address*

CAPTCHA

Third Quarter 2023 Financial Results and Business Update

Related Articles

VolitionRx Appoints LifeSci Advisors as Investor Relations Consultants

Study shows Nu.Q® Lung Cancer Test differentiated malignant and benign nodules found by Low Dose CT screening.

Subscribe for Volition product updates.

Or, click here for Investor Updates and press releases.

Contact